Repetitive TMS for Tourette Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Tourette SyndromeRepetitive TMS - Device
Eligibility
10 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help determine if magnetic stimulation of the brain can help people with Tourette Syndrome better control their movements.

Eligible Conditions
  • Tourette Syndrome

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Immediately after Repetitive Transcranial Magnetic Stimulation

Immediately after Repetitive Transcranial Magnetic Stimulation
Stop Signal Reaction Time (SSRT)

Trial Safety

Trial Design

1 Treatment Group

Repetitive TMS
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Repetitive TMS · No Placebo Group · N/A

Repetitive TMS
Device
Experimental Group · 1 Intervention: Repetitive TMS · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: immediately after repetitive transcranial magnetic stimulation

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
756 Previous Clinical Trials
5,421,236 Total Patients Enrolled
3 Trials studying Tourette Syndrome
116 Patients Enrolled for Tourette Syndrome
Steve W. Wu, MDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Eligibility Criteria

Age 10 - 17 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: